Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2

CJ Peach, VW Mignone, MA Arruda… - International journal of …, 2018 - mdpi.com
Vascular endothelial growth factor-A (VEGF-A) is a key mediator of angiogenesis, signalling
via the class IV tyrosine kinase receptor family of VEGF Receptors (VEGFRs). Although …

The VEGF/VEGFR axis revisited: implications for cancer therapy

P Mabeta, V Steenkamp - International journal of molecular sciences, 2022 - mdpi.com
The vascular endothelial growth factor (VEGF)/vascular endothelial growth factor receptor
(VEGFR) axis is indispensable in the process of angiogenesis and has been implicated as a …

Advances in surgical applications of growth factors for wound healing

S Yamakawa, K Hayashida - Burns & trauma, 2019 - academic.oup.com
Growth factors have recently gained clinical importance for wound management. Application
of recombinant growth factors has been shown to mimic cell migration, proliferation, and …

HEK293 in cell biology and cancer research: phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution

AA Stepanenko, VV Dmitrenko - Gene, 2015 - Elsevier
Abstract 293 cell line (widely known as the Human Embryonic Kidney 293 cells) and its
derivatives were the most used cells after HeLa in cell biology studies and after CHO in …

Therapeutic advances of targeting receptor tyrosine kinases in cancer

C Tomuleasa, AB Tigu, R Munteanu… - … and Targeted Therapy, 2024 - nature.com
Receptor tyrosine kinases (RTKs), a category of transmembrane receptors, have gained
significant clinical attention in oncology due to their central role in cancer pathogenesis …

Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning

P Vempati, AS Popel, F Mac Gabhann - Cytokine & growth factor reviews, 2014 - Elsevier
The regulation of vascular endothelial growth factor A (VEGF) is critical to
neovascularization in numerous tissues under physiological and pathological conditions …

Drug therapies and delivery mechanisms to treat perturbed skin wound healing

JS Chin, L Madden, SY Chew, DL Becker - Advanced Drug Delivery …, 2019 - Elsevier
Acute wound healing is an orderly process of four overlapping events: haemostasis,
inflammation, proliferation and remodelling. A drug delivery system with a temporal control …

Role and therapeutic potential of VEGF in the nervous system

C Ruiz de Almodovar, D Lambrechts… - Physiological …, 2009 - journals.physiology.org
The development of the nervous and vascular systems constitutes primary events in the
evolution of the animal kingdom; the former provides electrical stimuli and coordination …

Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing …

TN Demidova-Rice, MR Hamblin… - Advances in skin & …, 2012 - journals.lww.com
This is the second of 2 articles that discuss the biology and pathophysiology of wound
healing, reviewing the role that growth factors play in this process and describing the current …

Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells

TT Chen, A Luque, S Lee, SM Anderson… - Journal of cell …, 2010 - rupress.org
VEGF can be secreted in multiple isoforms with variable affinity for extracellular proteins and
different abilities to induce vascular morphogenesis, but the molecular mechanisms behind …